(MENAFN- ValueWalk)
March was a good month for the stock market, with the s&p 500 gaining about 3.5%. However, the s&p midcap 400 lost 3.41% for the month, while year to date, it is up almost 1%. Let's take a look at the five best- and worst-performing mid-cap stocks in March 2023. Table of Contents show
the five best-performing mid-cap stocks in march 2023
5. bridgebio pharma (52%)
4. lifestance health group (53%)
3. c3.ai inc (58%)
2. enovix (70%)
1. provention bio (193%)
the five worst-performing mid-cap stocks in march 2023
5. umb financial (-34%)
4. comerica (-36%)
3. zions bancorp (-38%)
2. western alliance bancorp. (-52%)
1. first republic bank (-88%)
The Five Best-Performing Mid-Cap Stocks In March 2023
We used the March return data on mid-cap stocks from finviz.com to rank the five best- and worst-performing mid-cap stocks in March 2023. Here were the five best-performing mid-cap stocks in March 2023:
Get The Full Series in PDF
Get the entire 10-part series on Charlie Munger in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.
q1 2023 hedge fund letters, conferences and more
Gates Capital Management Reduces Risk After Rare Down Year [Exclusive]Gates Capital Management's ECF Value Funds have a fantastic track record. The funds (full-name Excess Cash Flow Value Funds), which invest in an event-driven equity and credit strategy, have produced a 12.6% annualised return over the past 26 years. The funds added 7.7% overall in the second half of 2022, outperforming the 3.4% return for read more
5. BridgeBio Pharma (52%)
Founded in 2015 and headquartered in Palo Alto, California, this company identifies and advances transformative medicines to treat patients suffering from Mendelian diseases. BridgeBio Pharma Inc (NASDAQ:BBIO) shares are up by almost 105% year to date, bringing their 12-month gain to almost 36%.
At the time of this writing, BridgeBio Pharma shares are trading at around $15.70 with a 52-week range of $4.98 to $19.95, giving the company a market capitalization of more than $2.4 billion.
4. LifeStance Health Group (53%)
Founded in 2017 and headquartered in Scottsdale, Arizona, this company offers outpatient mental health services and telehealth services. Lifestance Health Group Inc (NASDAQ:LFST) shares are up by almost 59% year to date but remain in the red for the past year, down almost 21% over the last 12 months.
At the time of this writing, LifeStance Health Group shares are trading at around $7.80 with a 52-week range of $4.22 to $11.25, giving the company a market capitalization of more than $2.9 billion.
3. C3.ai Inc (58%)
Founded in 2009 and headquartered in Redwood City, California, this company deals in enterprise artificial intelligence (AI) software for digital transformation. c3.ai inc (NYSE:AI) shares are up by over 104% year to date, bringing them to a 12-month gain of over 7%.
At the time of this writing, C3.ai Inc shares are trading at around $22.60 with a 52-week range of $10.16 to $34.68, giving the company a market capitalization of more than $2.5 billion.
2. Enovix (70%)
Founded in 2006 and headquartered in Fremont, California, this company designs and develops silicon-anode lithium-ion batteries. After March's gain enovix corp (NASDAQ:ENVX) shares are down by more than 1% year to date and down almost 1% over the last year.
At the time of this writing, Enovix shares are trading at around $12.50 with a 52-week range of $6.50 to $26.30, giving the company a market capitalization of more than $1.9 billion.
1. Provention Bio (193%)
Founded in 2016 and headquartered in Red Bank, New Jersey, Provention Bio Inc (NASDAQ:PRVB) is a clinical-stage biopharmaceutical company that develops novel therapeutics and solutions. Provention Bio shares are up by almost 130% year to date, capping their 12-month gain at more than 249%.
At the time of this writing, Provention Bio shares are trading at around $24.20 with a 52-week range of $3.19 to $24.37, giving the company a market capitalization of more than $2.2 billion.
The Five Worst-Performing Mid-Cap Stocks In March 2023
These were the five worst-performing mid-cap stocks in March 2023:
5. UMB Financial (-34%)
Founded in 1967 and headquartered in Kansas City, Missouri, this company offers bank and asset management services. UMB Financial Corp (NASDAQ:UMBF) shares are down by more than 29% year to date, capping their 12-month decline at almost 37%.
At the time of this writing, UMB Financial shares are trading at around $58.80 with a 52-week range of $51.28 to $99.19, giving the company a market capitalization of more than $2.8 billion.
4. Comerica (-36%)
Founded in 1973 and headquartered in Dallas, Texas, this company offers financial services. comerica incorporated (NYSE:CMA) shares are down by more than 36% year to date, bringing their 12-month decline to almost 52%.
At the time of this writing, Comerica shares have a 52-week range of $29.17 to $91.33 and are trading at around $42.50, giving the company a market capitalization of more than $5.4 billion.
3. Zions Bancorp (-38%)
Founded in 1961 and headquartered in Salt Lake City, Utah, Zions Bancorp is a bank holding company that offers full banking and related services. Zions Bancorporation (NASDAQ:ZION) shares are down by over 40% year to date, bringing their 12-month decline to more than 53%.
At the time of this writing, Zions Bancorp shares have a 52-week range of $22.55 to $66.90 and are trading at around $29.20, giving the company a market capitalization of more than $4.3 billion.
2. Western Alliance Bancorp. (-52%)
Founded in 1995 and headquartered in Phoenix, Arizona, Western Alliance is a bank holding company that offers lending, treasury management, deposit and international banking services. western alliance bancorporation (NYSE:WAL) shares are down by more than 48% year to date, capping their decline at more than 59% over the last year.
At the time of this writing, Western Alliance Bancorp shares have a 52-week range of $7.46 to $86.87 and are trading at around $30.10, giving the company a market capitalization of more than $3.3 billion.
1. First Republic Bank (-88%)
Founded in 1985 and headquartered in San Francisco, California, this company offers private banking, business banking, wealth management and real estate lending services. first republic bank (NYSE:FRC) shares are down by over 88% year to date, bringing their 12-month decline to more than 91%.
At the time of this writing, First Republic Bank shares have a 52-week range of $11.52 to $171.09 and are trading at around $13.50, giving the company a market capitalization of more than $2.5 billion.